Measures for Care of Cancer Patients During COVID-19 Outbreak in China

JAMA Oncology

EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, APRIL 1, 2020

Media advisory: The full article is linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.1198?guestAccessKey=9dad6790-0e1e-41c8-92a3-65ea2ce138c4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040120

 

What The Viewpoint Says: The authors describe measures taken to reduce the risk of transmitting severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) to medical staff and cancer patients seeking treatment during the COVID-19 outbreak in China.

Authors: Jie Wang, M.D., Ph.D., and Jie He, M.D., of the Chinese Academy of Medical Sciences & Peking Union Medical College in Beijing, are the corresponding authors.

 

(doi:10.1001/jamaoncol.2020.1198)

Editor’s Note: Please see the articles for additional information, including other authors, author contributions and affiliations, conflicts of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.